List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #36,901 to #36,950.
- NNT → Number needed to treat
- NO → Nitric oxide
- NO-PAIN → Nitric Oxide In Peripheral Arterial Insufficiency
- NOAEL → No observable adverse effect level (NOAEL)
- NOCIRC → National Organization of Circumcision Information Resource Centers
- NOD2-associated disease-Blau → Blau syndrome
- NORDIL → Nordic Diltiazem Study
- NORML → National Organization for the Reform of Marijuana Laws
- NORVIT → Norwegian Vitamin Trial
- NOS → Nitric oxide synthase
- NOS2A → Nitric oxide synthase 2A
- NOS3 → Endothelial NOS
- NOTCH3 → Notch 3
- NOTES → Natural orifice transluminal endoscopic surgery
- NOTOC → Help:Section
- NO receptor → Guanylate cyclase
- NO synthase → Nitric oxide synthase
- NOx → Nitrogen oxide
- NP101 → Sumatriptan
- NPC → Nasopharyngeal carcinoma
- NPHP2 → INVS
- NPHP5 → IQCB1
- NPHP6 → CEP290
- NPHP7 → GLIS2
- NPHP8 → RPGRIP1L
- NPM1 gene → NPM1
- NPPB → Brain natriuretic peptide
- NPR-A → Atrial natriuretic peptide receptor
- NPRA → Atrial natriuretic factor receptor
- NPS → Nail-patella syndrome
- NPU → Net protein utilization
- NPV → Negative predictive value
- NPWT → Negative pressure wound therapy
- NPXpY → Insulin receptor substrate
- NPY → Neuropeptide Y
- NPY receptor → Neuropeptide Y receptor
- NR0B1 → DAX1
- NR4A2 → Nuclear receptor related 1 protein
- NRAS → Neuroblastoma RAS viral oncogene homolog
- NRAS gene → Neuroblastoma RAS viral oncogene homolog
- NREM → Non-rapid eye movement sleep
- NREM sleep → Non-rapid eye movement sleep
- NREM sleep arousal disorder → Non-rapid eye movement sleep arousal disorder
- NRG1 → Neuregulin 1
- NRH → Nodular regenerative hyperplasia
- NRMI-2 → National Registry Of Myocardial Infarction (Second Phase)
- NS → Noonan syndrome
- NS-RED → Sleep eating
- NS1 → NS1 Influenza Protein
- NSAID → Non-steroidal anti-inflammatory drug